Alla Chem, LLC
Records under this name other than the patents Alla Chem, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 9 of 9 · Back to Alla Chem, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,552,005 | (EN) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,790,207 | Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods Lapsed on the fee record Ended Oct 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 17, 2025 | From the USPTO record |
| US 10,266,558 | Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof Lapsed on the fee record Ended Apr 23, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2023 | From the USPTO record |
| US 9,370,576 | Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same Lapsed on the fee record Ended Jun 21, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 21, 2020 | From the USPTO record |
| US 8,889,701 | Substituted (S)-(2R,3R,5R)-3-hydroxy-(5-pyrimidin-1-yl)tetrahydrofuran-2-ylmethyl aryl phosphoramidate Lapsed on the fee record Ended Nov 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2018 | From the USPTO record |
| US 8,541,437 | Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereof Lapsed on the fee record Ended Sep 24, 2017 · From the USPTO record | Lapsed on the fee record | Ended Sep 24, 2017 | From the USPTO record |
| US 8,486,936 | Antagonist of smoothened Lapsed on the fee record Ended Jul 16, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2017 | From the USPTO record |
| US 8,486,945 | Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system Formerly held Lapsed on the fee record Ended Jul 16, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2017 | From the USPTO record |
| US 8,329,689 | Substituted indoles and a method for the production and use thereof Formerly held Lapsed on the fee record Ended Dec 11, 2016 · From the USPTO record | Lapsed on the fee record | Ended Dec 11, 2016 | From the USPTO record |